Matches in SemOpenAlex for { <https://semopenalex.org/work/W1955907623> ?p ?o ?g. }
- W1955907623 endingPage "92" @default.
- W1955907623 startingPage "81" @default.
- W1955907623 abstract "Since it was identified in 1963 as the antileukemic agent in guinea pig serum, l ‐asparaginase (ASNase) has become an integral component of chemotherapy protocols to treat patients with acute lymphoblastic leukemia (ALL). Escherichia coli and Erwinia chrysanthemi provide the sources of ASNase used clinically today. From the time ASNase was first introduced into treatment protocols, the 5‐year survival rate has increased significantly, particularly in children and adolescents. E. coli –derived ASNase was approved in 1978 to be used as part of a multiagent chemotherapy to treat ALL. However, the development of hypersensitivity in 10–30% of patients often leads to treatment discontinuation. E. chrysanthemi –derived ASNase (referred to herein as ASNase Erwinia chrysanthemi ) is immunologically distinct from E. coli ASNase and therefore does not cross‐react with the E. coli enzyme. In 2011, ASNase Erwinia chrysanthemi was approved in the United States for patients who develop hypersensitivity to E. coli –derived ASNase. When indicated, a switch from ASNase E. coli to ASNase E. chrysanthemi allows patients to continue to receive treatment and maintain therapeutic levels of ASNase activity. Therapeutic drug monitoring may help ensure that therapeutic enzyme levels are maintained. Pegylated recombinant ASNase Erwinia chrysanthemi is currently being developed to improve pharmacokinetic properties and reduce immunogenicity." @default.
- W1955907623 created "2016-06-24" @default.
- W1955907623 creator A5001477884 @default.
- W1955907623 creator A5012643167 @default.
- W1955907623 creator A5023214494 @default.
- W1955907623 creator A5042849087 @default.
- W1955907623 creator A5071056027 @default.
- W1955907623 date "2014-08-05" @default.
- W1955907623 modified "2023-10-12" @default.
- W1955907623 title "Development of asparaginase <i>Erwinia chrysanthemi</i> for the treatment of acute lymphoblastic leukemia" @default.
- W1955907623 cites W130421510 @default.
- W1955907623 cites W142226155 @default.
- W1955907623 cites W1490840859 @default.
- W1955907623 cites W1506630672 @default.
- W1955907623 cites W1887863677 @default.
- W1955907623 cites W1939497674 @default.
- W1955907623 cites W1940732706 @default.
- W1955907623 cites W1944430150 @default.
- W1955907623 cites W1965542498 @default.
- W1955907623 cites W1965634393 @default.
- W1955907623 cites W1965769627 @default.
- W1955907623 cites W1966763079 @default.
- W1955907623 cites W1968151924 @default.
- W1955907623 cites W1986395681 @default.
- W1955907623 cites W1986734312 @default.
- W1955907623 cites W1987446594 @default.
- W1955907623 cites W1987590182 @default.
- W1955907623 cites W1989771063 @default.
- W1955907623 cites W1995007817 @default.
- W1955907623 cites W1996838280 @default.
- W1955907623 cites W1998762015 @default.
- W1955907623 cites W2004681740 @default.
- W1955907623 cites W2005688611 @default.
- W1955907623 cites W2005753411 @default.
- W1955907623 cites W2007102329 @default.
- W1955907623 cites W2010002712 @default.
- W1955907623 cites W2011332592 @default.
- W1955907623 cites W2014405408 @default.
- W1955907623 cites W2014804837 @default.
- W1955907623 cites W2016833582 @default.
- W1955907623 cites W2017265604 @default.
- W1955907623 cites W2018374431 @default.
- W1955907623 cites W2021422854 @default.
- W1955907623 cites W2021985608 @default.
- W1955907623 cites W2024777863 @default.
- W1955907623 cites W2028579560 @default.
- W1955907623 cites W2032519529 @default.
- W1955907623 cites W2047657755 @default.
- W1955907623 cites W2049552282 @default.
- W1955907623 cites W2052816946 @default.
- W1955907623 cites W2053852136 @default.
- W1955907623 cites W2056562985 @default.
- W1955907623 cites W2058713665 @default.
- W1955907623 cites W2060440673 @default.
- W1955907623 cites W2067607205 @default.
- W1955907623 cites W2068619849 @default.
- W1955907623 cites W2070315143 @default.
- W1955907623 cites W2070317865 @default.
- W1955907623 cites W2075139424 @default.
- W1955907623 cites W2080828049 @default.
- W1955907623 cites W2081127271 @default.
- W1955907623 cites W2084089666 @default.
- W1955907623 cites W2084612827 @default.
- W1955907623 cites W2086930991 @default.
- W1955907623 cites W2096489857 @default.
- W1955907623 cites W2100462105 @default.
- W1955907623 cites W2103347449 @default.
- W1955907623 cites W2105435030 @default.
- W1955907623 cites W2113512182 @default.
- W1955907623 cites W2114064238 @default.
- W1955907623 cites W2114340167 @default.
- W1955907623 cites W2117623554 @default.
- W1955907623 cites W2127153931 @default.
- W1955907623 cites W2133750402 @default.
- W1955907623 cites W2140819149 @default.
- W1955907623 cites W2144236207 @default.
- W1955907623 cites W2144309603 @default.
- W1955907623 cites W2146524976 @default.
- W1955907623 cites W2148631711 @default.
- W1955907623 cites W2156840245 @default.
- W1955907623 cites W2169732420 @default.
- W1955907623 cites W2313577290 @default.
- W1955907623 cites W2582808171 @default.
- W1955907623 cites W2587810165 @default.
- W1955907623 cites W2592175556 @default.
- W1955907623 doi "https://doi.org/10.1111/nyas.12496" @default.
- W1955907623 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25098829" @default.
- W1955907623 hasPublicationYear "2014" @default.
- W1955907623 type Work @default.
- W1955907623 sameAs 1955907623 @default.
- W1955907623 citedByCount "38" @default.
- W1955907623 countsByYear W19559076232014 @default.
- W1955907623 countsByYear W19559076232015 @default.
- W1955907623 countsByYear W19559076232016 @default.
- W1955907623 countsByYear W19559076232017 @default.
- W1955907623 countsByYear W19559076232018 @default.
- W1955907623 countsByYear W19559076232019 @default.
- W1955907623 countsByYear W19559076232020 @default.